实用肿瘤学杂志 ›› 2025, Vol. 39 ›› Issue (3): 184-190.doi: 10.11904/j.issn.1002-3070.2025.03.003

• 基础研究 • 上一篇    下一篇

下调FKBP4通过阻断PI3K/Akt/mTOR信号通路抑制非小细胞肺癌的恶性进展

卢菊萍1, 胡军2, 邓永明1, 廖淑芳1   

  1. 1.三明市第一医院病理科(三明 365000);
    2.三明市第一医院干部病房
  • 收稿日期:2024-11-20 修回日期:2025-03-24 出版日期:2025-06-28 发布日期:2025-07-02
  • 通讯作者: 卢菊萍,E-mail:514864692@qq.com
  • 作者简介:卢菊萍,女,(1988—),本科,主治医师,从事呼吸系统疾病方向的研究。

Downregulation of FKBP4 inhibits the malignant progression of non-small cell lung cancer by blocking the PI3K/Akt/mTOR signaling pathway

LU Juping1, HU Jun2, DENG Yongming1, LIAO Shufang1   

  1. 1. Department of Pathology,Sanming First Hospital,Sanming 365000,China;
    2. Cadre Ward,The First Hospital of Sanming City
  • Received:2024-11-20 Revised:2025-03-24 Online:2025-06-28 Published:2025-07-02

摘要: 目的 探究下调FK506结合蛋白4(FK506 binding protein 4,FKBP4)能否通过阻断PI3K/Akt/mTOR信号通路抑制非小细胞肺癌(non-small cell lung cancer,NSCLC)的恶性进展。方法 培养NSCLC细胞系A549、H1975、H358和PC-9以及人支气管上皮细胞(human bronchial epithelial cell,HBE),采用qRT-PCR检测FKBP4在上述细胞中的表达水平,并筛选出与HBE细胞相比FKBP4差异表达最显著的NSCLC细胞系。将FKBP4-siRNA和NC-siRNA分别转染至A549细胞,根据转染物的不同将细胞分为si-FKBP4组和NC组,采用CCK-8法检测si-FKBP4组和NC组细胞增殖能力,采用流式细胞术检测细胞凋亡率,采用划痕愈合实验检测细胞的迁移能力,采用Transwell实验检测细胞的侵袭能力,采用Western blot实验检测PI3K及其下游效应物Akt和mTOR的蛋白总表达水平和磷酸化水平。结果 FKBP4在A549、H1975、H358和PC-9细胞中的表达水平均显著高于HBE细胞系(P<0.05),且在A549细胞系中表达水平最高(P<0.001);下调FKBP4可抑制A549细胞增殖、侵袭和迁移,促进A549细胞凋亡(P<0.001)。此外,下调FKBP4可以抑制PI3K、Akt和mTOR磷酸化,阻断PI3K/Akt/mTOR信号通路。结论 下调FKBP4可通过阻断PI3K/Akt/mTOR信号通路抑制NSCLC细胞的增殖、侵袭和迁移,并促进NSCLC细胞的凋亡。

关键词: 非小细胞肺癌, FK506结合蛋白4, 磷脂酰肌醇-3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路, 增殖, 凋亡

Abstract: Objective The aim of this study was to investigate whether downregulation of FK506 binding protein 4(FKBP4)could inhibit the malignant progression of non-small cell lung cancer(NSCLC)by blocking the PI3K/Akt/mTOR signaling pathway. Methods NSCLC A549,H1975,H358 and PC-9 cell lines,as well as human bronchial epithelial cells(HBE)were routinely cultured.The expression of FKBP4 in these cells was detected by qRT-PCR,and NSCLC cell lines with the most significant different expression of FKBP4 compared with HBE cells was screened.FKBP4 siRNA and NC siRNA were transfected into A549 cells,which were divided into the si-FKBP4 group and NC group.CCK-8 assay was used to detect the proliferative ability of si-FKBP4 group and NC group,flow cytometry was used to detect the apoptosis rate,scratch healing assay was used to detect the migration ability,Transwell assay was used to detect the invasion ability,and Western blot was used to detect the total and phosphorylation protein expression of PI3K and its downstream effectors Akt and mTOR. Results The expression of FKBP4 in A549 cells,H1975 cells,H358 cells and PC-9 cells were significantly higher than those in HBE cells(P<0.05),and its expression in A549 cells was the highest(P<0.001).Downregulation of FKBP4 could inhibit the proliferation,invasion and migration of A549 cells and promote the apoptosis of A549 cells(P<0.001).In addition,downregulation of FKBP4 also could inhibit the phosphorylation of PI3K,Akt and mTOR,resulting in blocking the PI3K/Akt/mTOR signaling pathway. Conclusion Downregulation of FKBP4 can inhibit the proliferation,invasion and migration of NSCLC cells by blocking the PI3K/Akt/mTOR signaling pathway,and promote the apoptosis of NSCLC cells.

Key words: Non-small cell lung cancer, FK506 binding protein 4, Phosphatidylinositol-3-kinase/protein kinase B/mammalian rapamycin target protein signaling pathway, Proliferation, Apoptosis

中图分类号: